Navigation Links
Cabinet Clears Purchase Preference Policy for Pharma PSUs

The Government today said the central departments, public sector undertakings and autonomous bodies will give first preference to central pharma PSUs like IDPL// and their subsidiaries for purchasing 102 medicines for a period of five years.

As per a decision of the Cabinet, which met here today, the first preference will also be given to these pharma PSUs and their subsidiaries by state governments in their purchases which are funded by the Centre.

The purchasing departments may invite limited tenders from pharma PSUs and their subsidiaries or purchase directly from them at notified price with a discount up to 35 per cent, Information and Broadcasting Minister P R Dasmunsi told reporters after the Cabinet meeting.

If no pharma CPSE is forthcoming to supply these medicines, the purchasing departments would be at liberty to buy from other manufacturers, I& B Minister P R Dasmunsi said.

The purchasing departmens would purchase from these PSUs, and their subsidiaries, subject to their meeting Good Manufacturing Practices norms.

The purpose of the Purchase Preference Policy is to make available quality drugs under various health schemes and help in optimum utilisation of assets of these public sector units, Dasmunsi said.

The size of pharma market in the country stands at Rs 50,000 crore, including exports of around Rs 17,000 crore. Of this, central departments purchase around Rs 2,000 crore of medicines and state governments account for another Rs 1,500-2,000 crore per annum for their health programmes.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Business model for Liver Institute cleared by Delhi Cabinet
2. Baby Acne Clears Up On Its Own
3. SC Clears Deck For Implementation Of Nutrition Scheme
4. Bangkoks Public Health Ministry Clears The Northern Province Of Bird Flu Epidemic
5. European Commission Clears Diabetic Insulin for Pregnant Women
6. Delhi Government Clears Healthcare Projects Worth Rs.1.13 bn
7. FDA Clears Breast Cancer Specific Molecular Prognostic Test
8. FDA Clears Critical Limb-Saving Vascular Device
9. The Risks Involved In Purchase Of Over The Counter Medications
10. Online Auction Results In Purchase of Chemicals
11. Aurobindo Pharma Purchases US Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ( http://www.firstalign.com ), ... latest Artificial Intelligence (AI) thinking, announced today the launch of its revamped web ... essential information that offers a more comprehensive understanding of the organization’s business and ...
(Date:9/20/2017)... Carolina (PRWEB) , ... September 20, 2017 , ... ... Laboratories as one of the Best Places to Work in the Research Triangle ... Quantum Workplace. Once nominated, a company had to meet a threshold in employee ...
(Date:9/20/2017)... ... 2017 , ... Doctors on Liens has added the medical group Bones and ... on a personal injury lien basis. Founded by Dr. Wayne Cheng, MD and Dr. ... experience with orthopedic injuries to patients in the Inland Empire. , Bones and Spines ...
(Date:9/20/2017)... ... September 20, 2017 , ... Mirror Mirror ... event , Look Awesome This Autumn with CoolSculpting®. Scheduled for Thursday, September 28th, ... , Mirror Mirror Beauty Boutique is Houston’s largest CoolSculpting provider, ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced ... Aligner clinical and commercial support services market) has entered into an agreement on ... Australia. , The PGSD is the first private Dental School to launch ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... Conference at the Grand Hyatt hotel in New York.  ... at 11:40 a.m. Eastern Time. A live ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... WILMINGTON, Del. , Sept. 6, 2017 NeuroRx, ... for Acute Suicidal Ideation and Behavior (ASIB), has been granted ... for its sequential therapy of NRX-100 (ketamine HCl) followed by ... patients in a pivotal trial of this sequential therapy targeting ... bipolar depression. 1 ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: